U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C20H30O
Molecular Weight 286.4516
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 4
Charge 0

SHOW SMILES / InChI
Structure of RETINOL

SMILES

CC(=C/CO)\C=C\C=C(C)\C=C\C1=C(C)CCCC1(C)C

InChI

InChIKey=FPIPGXGPPPQFEQ-OVSJKPMPSA-N
InChI=1S/C20H30O/c1-16(8-6-9-17(2)13-15-21)11-12-19-18(3)10-7-14-20(19,4)5/h6,8-9,11-13,21H,7,10,14-15H2,1-5H3/b9-6+,12-11+,16-8+,17-13+

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/8801161

Retonol, also known as Vitamin A1, is a vitamin found in food and used as a dietary supplement. It is used to treat and prevent vitamin A deficiency. It is also used to prevent further issues in those who have measles. Retinol is used as a metabolic precursor of retinoic acid to treat skin-related conditions, such as cellulite, skin aging, photodamage.

CNS Activity

Curator's Comment: Evidence indicates that retinol is transported by retinol binding protein across the blood–brain barrier and blood–CSF barrier to the CNS

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: O95237
Gene ID: 9227.0
Gene Symbol: LRAT
Target Organism: Homo sapiens (Human)
Target ID: Q96NR8
Gene ID: 145226.0
Gene Symbol: RDH12
Target Organism: Homo sapiens (Human)
Target ID: Q92781
Gene ID: 5959.0
Gene Symbol: RDH5
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
Unknown

Approved Use

Unknown
Preventing
Unknown

Approved Use

Unknown
Preventing
Unknown

Approved Use

Unknown
Primary
AQUASOL A

Approved Use

Used to treat and prevent symptoms of vitamin A deficiency such as xerophthalmia and night blindness. Used as a dietary supplement to prevent vitamin A deficiency in patients with GI diseases (e.g., malabsorption syndromes) and those with abnormal storage and transport of vitamin A (e.g., abetalipoproteinemia, protein deficiency, diabetes mellitus, hyperthyroidism, fever, liver disease, cystic fibrosis with hepatic involvement).

Launch Date

1949
Palliative
AQUASOL A

Approved Use

Children with severe measles have been found to have low serum concentrations of vitamin A; WHO and AAP recommend that vitamin A supplements be given to all children with acute measles, regardless of their country of residence.

Launch Date

1949
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Vitamin A abuse: development of cirrhosis despite cessation of vitamin A. A six-year clinical and histopathologic follow-up.
1992 Dec
Use of vitamin supplements and cataract: the Blue Mountains Eye Study.
2001 Jul
Retrospective analysis of drug-induced urticaria and angioedema: a survey of 2287 patients.
2001 Nov
The anemia of vitamin A deficiency: epidemiology and pathogenesis.
2002 Apr
DNA microarray technology reveals similar gene expression patterns in rats with vitamin a deficiency and chemically induced colitis.
2002 Aug
[Treatment of acne with consequences -- pseudotumor cerebri due to hypervitaminosis A].
2002 Jan 9
Zinc transporters in the rat mammary gland respond to marginal zinc and vitamin A intakes during lactation.
2002 Nov
[Basic aspects and measurement of the antioxidant vitamins A and E].
2002 Sep
PPARbeta regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation.
2003 Feb
Vitamin A deficiency leads to increased cell proliferation in olfactory epithelium of mature rats.
2003 Mar
Ocular side effects from herbal medicines and nutritional supplements.
2004 Oct
Differential effects of vitamin A on fetal lung growth and diaphragmatic formation in nitrofen-induced rat model.
2005
Alcohol, vitamin A, and cancer.
2005 Apr
What is the safe dose of vitamin A in children with measles?
2005 Apr
Retinoid receptor mRNA expression profiles in human bladder cancer specimens.
2005 Apr
Fortification of maize meal improved the nutritional status of 1-3-year-old African children.
2005 Aug
Effects of prenatal vitamins A, E, and C on the hypoplastic hearts of fetal rats with diaphragmatic hernia.
2005 Aug
Phospho-STAT5 accumulation in nuclear fractions from vitamin A-deficient rat liver.
2005 Jul 4
Effect of vitamin A content in cafeteria diet on the expression of nuclear receptors in rat subcutaneous adipose tissue.
2005 Jun
Vitamin a deficiency and anaemia in young children living in a malaria endemic district of western Kenya.
2005 Jun
Vitamin A deficiency induces prooxidant environment and inflammation in rat aorta.
2005 Jun
Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells.
2005 Oct
Comparison of indices of vitamin A status in children with chronic liver disease.
2005 Oct
Vitamin A regulation of BMP4 expression in the male germ line.
2005 Oct 1
Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle.
2005 Sep 20
Hypervitaminosis A resulting in DNA aberration in fetal transgenic mice (Muta Mouse).
2005 Sep 5
Effects of nitrofen and vitamins A, C and E on maturation of cultured human H441 pneumocytes.
2006
Vitamin A improves Pax3 expression that is decreased in the heart of rats with experimental diaphragmatic hernia.
2006 Feb
The acute and chronic toxic effects of vitamin A.
2006 Feb
Vitamin A inhibits pancreatic stellate cell activation: implications for treatment of pancreatic fibrosis.
2006 Jan
Patents

Sample Use Guides

Weekly single oral dose 7000 micrograms
Route of Administration: Oral
The role of vitamin A (2.72 μM/7 ml culture), a naturally occurring antioxidant upon arsenic-induced genotoxicity; with respect to chromosomal aberrations (structural and numerical) and micronuclei. Whole blood cultures set for 72 h were exposed to test chemicals for a period of 24 h ahead of harvesting. Arsenic concentrations tested in the present study are 0.36, 0.72 and 1.4 μM/7 ml culture. Mitomycin C (MMC), the direct acting mutagen was used as positive control.
Name Type Language
NSC-122759
Preferred Name English
RETINOL
HSDB   INCI   INN   WHO-DD  
INN   INCI  
Official Name English
Retinol [WHO-DD]
Common Name English
VITAMIN A ALCOHOL
Common Name English
(2E,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYLCYCLOHEX-1-EN-1-YL)NONA-2,4,6,8-TETRAEN-1-OL
Systematic Name English
ALL-TRANS-RETINOL
Common Name English
retinol [INN]
Common Name English
VITAMIN A [MI]
Common Name English
RETINOL [HSDB]
Common Name English
Classification Tree Code System Code
WHO-VATC QR01AX02
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
LOINC 20947-8
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
LOINC 14905-4
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-VATC QS01XA02
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
NCI_THESAURUS C68299
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
NCI_THESAURUS C938
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-VATC QD10AD02
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-ESSENTIAL MEDICINES LIST 27
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
LOINC 20948-6
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
DSLD 3441 (Number of products:6)
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-ATC S01XA02
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-ATC A11CA01
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
EU-Orphan Drug EU/3/17/1895
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
LOINC 20946-0
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
LOINC 87673-0
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
LOINC 2923-1
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-ATC D10AD02
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-ATC R01AX02
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
WHO-VATC QA11CA01
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
LOINC 2922-3
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
Code System Code Type Description
DRUG CENTRAL
2831
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
EPA CompTox
DTXSID3023556
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
CHEBI
45479
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
CAS
68-26-8
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
RXCUI
1367187
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY RxNorm
PUBCHEM
445354
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
DRUG BANK
DB00162
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
HSDB
815
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
ChEMBL
CHEMBL986
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
CHEBI
50211
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
INN
2243
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
SMS_ID
100000076424
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
WIKIPEDIA
RETINOL
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
FDA UNII
G2SH0XKK91
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
CHEBI
17336
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
ECHA (EC/EINECS)
200-683-7
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
EVMPD
SUB16102MIG
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
NCI_THESAURUS
C68302
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
DAILYMED
G2SH0XKK91
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
NSC
122759
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY
MERCK INDEX
m11481
Created by admin on Mon Mar 31 18:12:19 GMT 2025 , Edited by admin on Mon Mar 31 18:12:19 GMT 2025
PRIMARY Merck Index